241 Phase II study of bl-weekly oxaliplatin, UFT and leucovorin (OXA-UFT-LV) in pretreated metastatic colorectal cancer(MCRC)

E.Gonza′lez-Flores; R.Luque; J.Valdivia; V.Conde; A.Irigoyen; J.R.Delgado; P.Ballesteros; A.Bezares; E.Lo′pez; J.Belo′n

首页> 外文期刊>European Journal of Cancer Supplements >241 Phase II study of bl-weekly oxaliplatin, UFT and leucovorin (OXA-UFT-LV) in pretreated metastatic colorectal cancer(MCRC)

【24h】

241 Phase II study of bl-weekly oxaliplatin, UFT and leucovorin (OXA-UFT-LV) in pretreated metastatic colorectal cancer(MCRC)

机译：241每周一次的每周一次奥沙利铂，UFT和亚叶酸钙（OXA-UFT-LV）在预处理的转移性结直肠癌（MCRC）中的II期研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共页
作者
E.Gonza′lez-Flores; R.Luque; J.Valdivia; V.Conde; A.Irigoyen; J.R.Delgado; P.Ballesteros; A.Bezares; E.Lo′pez; J.Belo′n;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. |[lsquo]|A phase II study of oral uracil|[sol]|ftorafur (UFT|[reg]|) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer|[rsquo]| [J] . J Bennouna, H Perrier, B Paillot, British Journal of Cancer . 2006,第1期

机译：| [lsquo | II口服尿嘧啶| [sol] |氟尿酸（UFT | [reg] |）加亚叶酸钙联合奥沙利铂（TEGAFOX）作为转移性结直肠癌患者的一线治疗的II期研究|
2. A multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancer. [J] . Kato K, Inaba Y, Tsuji Y, Japanese journal of clinical oncology. . 2011,第1期

机译：多中心II期研究了5-FU，亚叶酸钙和奥沙利铂（FOLFOX6）在转移性结直肠癌治疗前患者中的作用。
3. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer. [J] . Chiara S, Nobile MT, Gozza A, Anticancer Research: International Journal of Cancer Research and Treatment . 2004,第1期

机译：预处理的转移性结直肠癌患者每周进行奥沙利铂和大剂量5-氟尿嘧啶加亚叶酸钙输注的II期研究。
4. Single Cell Genomic Profiling of Circulating Tumor Cells (CTCs) from Metastatic Colorectal Cancer (mCRC) Identify Tumor Heterogeneity and Rare Somatic Driver Alterations [C] . Stephanie Greene, Angel Rodriguez, Jerry Lee, International Molecular Medicine Tri-Conference. . 2016

机译：转移结直肠癌（MCRC）的循环肿瘤细胞（CTC）的单细胞基因组分析识别肿瘤异质性和稀有躯体驾驶员改变
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. ‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer [O] . J Bennouna, H Perrier, B Paillot, 2006

机译：‘口服尿嘧啶/氟尿嘧啶（UFT®）加亚叶酸钙联合奥沙利铂（TEGAFOX）作为转移性结直肠癌患者的一线治疗的II期研究
7. ‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer' [O] . Bennouna, J, Perrier, H, Paillot, B, 2005

机译：‘口服尿嘧啶/氟尿嘧啶（UFT®）加亚叶酸钙联合奥沙利铂（TEGAFOX）作为转移性结直肠癌患者的一线治疗的II期研究”

241 Phase II study of bl-weekly oxaliplatin, UFT and leucovorin (OXA-UFT-LV) in pretreated metastatic colorectal cancer(MCRC)

著录项

相似文献

相关主题

期刊订阅